Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a targeted drug keep hodgkin lymphoma away after transplant?

NCT ID NCT05100056

Recruiting now Disease control Sponsor: Takeda Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is checking how well the drug brentuximab vedotin works for adults with Hodgkin lymphoma who have had a stem cell transplant. Researchers will track 70 participants for about 2 years to see if the drug helps prevent the cancer from coming back. It is an observational study, meaning the drug is given as part of normal care, not as an experiment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
brentuximab vedotin
What this could lead to
If successful, this study could confirm that brentuximab vedotin helps keep Hodgkin lymphoma from returning after a stem cell transplant.
What could go wrong
This is an observational study, not a controlled trial, so results may be less reliable. It is small (70 people) and only follows patients for about 2 years, so long-term benefits or risks are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hodgkins lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HODGKIN LYMPHOMA

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Centrum Onkologii Ziemi Lubelskiej im. sw. Jana z Dukli

    RECRUITING

    Lublin, Lublin Voivodeship, 20-090, Poland

  • Instytut Hematologii i Transfuzjologii

    RECRUITING

    Warsaw, Masovian Voivodeship, 02-776, Poland

  • NU-MED Specjalistyczny Szpital Onkologiczny Tomaszow Mazowiecki

    RECRUITING

    Tomaszow Mazowiecki, Masovian Voivodeship, 97-200, Poland

  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy

    RECRUITING

    Warsaw, Masovian Voivodeship, 02-781, Poland

  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy Oddzial w Krakowie

    RECRUITING

    Krakow, Lesser Poland Voivodeship, 31-115, Poland

  • Samodzielny Publiczny Szpital Kliniczny im. Andrzeja Mieleckiego Slskiego Uniwersytetu Medycznego w Katowicach

    RECRUITING

    Katowice, Slskie, 40-027, Poland

  • Samodzielny Publiczny Zaklad Opieki Zdrowotnej MSWiA z Warminsko - Mazurskim Centrum Onkologii w Olsztynie

    RECRUITING

    Olsztyn, Warmian-Masurian Voivodeship, 10-228, Poland

  • Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki w Krakowie

    RECRUITING

    Krakow, Lesser Poland Voivodeship, 31-501, Poland

  • Szpital Kliniczny Przemienienia Panskiego Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu

    RECRUITING

    Poznan, Greater Poland Voivodeship, 61-848, Poland

  • Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu

    RECRUITING

    Wroclaw, Dolnoslskie, 50-556, Poland

  • Uniwersyteckie Centrum Kliniczne WUM

    RECRUITING

    Warsaw, Masovian Voivodeship, 02-097, Poland

  • Uniwersyteckie Centrum Kliniczne, Gdansk

    RECRUITING

    Gdansk, Pomeranian Voivodeship, 80-214, Poland

    Contact Email: •••••@•••••

  • Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii, im. M. Kopernika w Lodzi

    RECRUITING

    Lodz, Łódź Voivodeship, 93-513, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.